Literature DB >> 18759667

Umbilical cord blood stem cells: induction of differentiation into mesenchymal lineages by cell-cell contacts with various mesenchymal cells.

Jung Park1, Viviane Setter, Viktor Wixler, Holm Schneider.   

Abstract

CD133(+) cells isolated from bone marrow, peripheral blood, or umbilical cord blood (UCB) represent an established source of transplantable hematopoietic progenitors. Further, there is increasing evidence that such CD133(+) cell isolates comprise subpopulations capable of differentiating into several mesenchymal lineages. In this study, we investigated conditions under which mesenchymal differentiation can be induced, particularly the role of cell-cell contacts with mesenchymal cells. A purified, nearly homogeneous CD133(+) population of human UCB cells was expanded by stimulation with platelet-derived growth factor and epidermal growth factor, labeled with the fluorescent marker DiI and cocultivated with rat osteoblasts, C2C12 myoblasts, or rat cardiomyocytes, respectively. In control experiments, the two cell types were separated by microporous membranes to avoid cell-cell contacts. Direct coculture of DiI-labeled UCB cells with the different mesenchymal cell populations resulted in both significant morphological changes and upregulation of lineage-specific markers. Expression of osteocalcin, myosin heavy chain, or alpha-actinin confirmed differentiation of the UCB cells into an osteoblastic, myoblastic, or cardiomyocytic phenotype, respectively. In contrast, coculture of UCB cells with the respective inducer cells under conditions preventing cell-cell contacts yielded minor, if any, evidence for such differentiation. Our data, thus, indicate that UCB cell expansion in vitro and subsequent direct cell-cell contacts with mesenchymal cells can induce their differentiation into mesenchymal lineages specific to the cell type they are in contact with. This finding has important implications for understanding the homing of adult stem cells and the promise of UCB as a cell source for tissue engineering and regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18759667     DOI: 10.1089/ten.tea.2007.0379

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  8 in total

1.  In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells.

Authors:  Sveva Bollini; Michela Pozzobon; Muriel Nobles; Johannes Riegler; Xuebin Dong; Martina Piccoli; Angela Chiavegato; Anthony N Price; Marco Ghionzoli; King K Cheung; Anna Cabrelle; Paul R O'Mahoney; Emanuele Cozzi; Saverio Sartore; Andrew Tinker; Mark F Lythgoe; Paolo De Coppi
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 2.  Cord blood--an alternative source for bone regeneration.

Authors:  Marcus Jäger; Christoph Zilkens; Bernd Bittersohl; Rüdiger Krauspe
Journal:  Stem Cell Rev Rep       Date:  2009-08-04       Impact factor: 5.739

3.  Human umbilical cord-derived mesenchymal stem cells differentiate into epidermal-like cells using a novel co-culture technique.

Authors:  Dongjie Li; Jiake Chai; Chuanan Shen; Yanfu Han; Tianjun Sun
Journal:  Cytotechnology       Date:  2014-06-21       Impact factor: 2.058

Review 4.  [Cell therapy in bone-healing disorders].

Authors:  M Jäger; P Hernigou; C Zilkens; M Herten; J Fischer; R Krauspe
Journal:  Orthopade       Date:  2010-04       Impact factor: 1.087

5.  Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis.

Authors:  Haruchika Masuda; Hiroto Iwasaki; Atsuhiko Kawamoto; Hiroshi Akimaru; Masakazu Ishikawa; Masaaki Ii; Tomoko Shizuno; Atsuko Sato; Rie Ito; Miki Horii; Hideyuki Ishida; Shunichi Kato; Takayuki Asahara
Journal:  Stem Cells Transl Med       Date:  2012-02-06       Impact factor: 6.940

6.  Cell therapy in bone healing disorders.

Authors:  Marcus Jäger; Philippe Hernigou; Christoph Zilkens; Monika Herten; Xinning Li; Johannes Fischer; Rüdiger Krauspe
Journal:  Orthop Rev (Pavia)       Date:  2010-09-23

Review 7.  Impact of umbilical cord blood-derived mesenchymal stem cells on cardiovascular research.

Authors:  Santiago Roura; Josep Maria Pujal; Carolina Gálvez-Montón; Antoni Bayes-Genis
Journal:  Biomed Res Int       Date:  2015-03-10       Impact factor: 3.411

8.  Human endothelial-like differentiated precursor cells maintain their endothelial characteristics when cocultured with mesenchymal stem cell and seeded onto human cancellous bone.

Authors:  Dirk Henrich; Kerstin Wilhelm; Joerg Warzecha; Johannes Frank; John Barker; Ingo Marzi; Caroline Seebach
Journal:  Mediators Inflamm       Date:  2013-02-17       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.